Impaired fibrinolysis due to OSA was first demonstrated by Rangemark et al., who analysed the concentrations of the primary fibrinolysis inhibitor, plasminogen activator inhibitor 1 [37]. Here, SERPINE1 is linked to obstructive sleep apnea syndrome.